Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and...
Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study)
About this item
Full title
Author / Creator
Dhamelincourt, Estelle , Descourt, Renaud , Rousseau-Bussac, Gaelle , Doubre, Hélène , Decroisette, Chantal , Demontrond, Pierre , Le Garff, Gwenaelle , Falchero, Lionel , Huchot, Eric , Vieillot, Sabine , Corre, Romain , Kazulinski, Laure , Bizieux, Acya , Bigay-Gamé, Laurence , Morel, Hugues , Molinier, Olivier , Chouaïd, Christos and Guisier, Florian
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
Although
ALK
-translocated (
ALK
+) advanced non-small cell lung cancers (aNSCLCs) are currently treated with second- or third-generation
ALK
inhibitors (ALK-TKIs), some patients respond durably to the first-generation ALK-TKI crizotinib.
Objective
This study aimed to describe the clinical characteristics of th...
Alternative Titles
Full title
Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study)
Authors, Artists and Contributors
Author / Creator
Descourt, Renaud
Rousseau-Bussac, Gaelle
Doubre, Hélène
Decroisette, Chantal
Demontrond, Pierre
Le Garff, Gwenaelle
Falchero, Lionel
Huchot, Eric
Vieillot, Sabine
Corre, Romain
Kazulinski, Laure
Bizieux, Acya
Bigay-Gamé, Laurence
Morel, Hugues
Molinier, Olivier
Chouaïd, Christos
Guisier, Florian
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2890360866
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2890360866
Other Identifiers
ISSN
1776-2596
E-ISSN
1776-260X
DOI
10.1007/s11523-023-01014-z
